The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer
Clinical trial NCT03444376 · COMPLETED
Trial details
- NCT number
- NCT03444376
- Sponsor
- Genexine, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-19
- Primary completion
- 2022-04-29
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.